tiprankstipranks
Advertisement
Advertisement
Alnylam Pharmaceuticals: Underpenetrated TTR Market and Strong Commercial Execution Support Buy Rating
PremiumRatingsAlnylam Pharmaceuticals: Underpenetrated TTR Market and Strong Commercial Execution Support Buy Rating
11d ago
Alnylam Pharmaceuticals: Durable ATTR Growth and Amvuttra Momentum Support Buy Rating and Upside Potential
Premium
Ratings
Alnylam Pharmaceuticals: Durable ATTR Growth and Amvuttra Momentum Support Buy Rating and Upside Potential
11d ago
Alnylam announces set of efforts to improve care for patients with ATTR-CM
Premium
The Fly
Alnylam announces set of efforts to improve care for patients with ATTR-CM
12d ago
Alnylam’s KARDIA-3 Hypertension Trial Reaches Completion, Raising Key Questions for ALNY Investors
PremiumCompany AnnouncementsAlnylam’s KARDIA-3 Hypertension Trial Reaches Completion, Raising Key Questions for ALNY Investors
1M ago
Balancing Short-Term Amvuttra Headwinds Against Solid TTR Growth: Rationale for Maintaining a Hold Rating
Premium
Ratings
Balancing Short-Term Amvuttra Headwinds Against Solid TTR Growth: Rationale for Maintaining a Hold Rating
1M ago
Alnylam’s New Phase 1 ALN-4285 Trial: What Early Safety Data Could Mean for ALNY Investors
Premium
Company Announcements
Alnylam’s New Phase 1 ALN-4285 Trial: What Early Safety Data Could Mean for ALNY Investors
1M ago
Alnylam upgraded to Buy from Hold at Freedom Capital
PremiumThe FlyAlnylam upgraded to Buy from Hold at Freedom Capital
2M ago
3 ‘Strong Buy’ Stocks to Buy Now, 2/13/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now, 2/13/2026, According to Top Analysts
2M ago
Alnylam price target lowered to $360 from $408 at Morgan Stanley
Premium
The Fly
Alnylam price target lowered to $360 from $408 at Morgan Stanley
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100